Immunity to and Prevention of Herpes Zoster

by Gershon, A.A.

• ISBN13: 9783211835562
• ISBN10: 3211835563
• Edition: 1st
• Format: Hardcover
• Copyright: 2001-07-01
• Publisher: SPRINGER

Summary

Varicella-zoster virus (VZV) causes both chickenpox and zoster. Fundamental to their prevention is an understanding of the natural history of VZV infection. This is a compilation of papers presented in March 1999 in Osaka, Japan, by internationally renowned researchers studying varicella-zoster virus and a vaccine used to prevent disease caused by this virus. The aim of the meeting was to explore progress made in basic and molecular biology of VZV and current understanding of latent infection and reactivation. Data concerning immune responses to VZV, mechanisms by which virus latency are controlled, and the latest information on vaccination to prevent varicella and zoster are presented and discussed.

Table of Contents

The current status of live attenuated varicella vaccine	1	(7)
Gershon, A. A.
Evidence for frequent reactivation of the Oka varicella vaccine strain in healthy vaccines	7	(10)
Krause, P. R.
Investigation of varicella-zoster virus variation by heteroduplex mobility assay	17	(10)
Barrett-Muir, W.
Hawrami, K.
Clarke, J.
Breuer, J.
Varicella-zoster virus with a lost gE epitope: evidence for immunological pressure by the human antibody response	27	(14)
Padilla, J. A.
Grose, C.
Biologic and geographic differences between vaccine and clinical varicella-zoster virus isolates	41	(8)
LaRussa, P. S.
Gershon, A. A.
Comparison of DNA sequence and transactivation activity of open reading frame 62 of Oka varicella vaccine and its parental viruses	49	(8)
Gomi, Y.
Imagawa, T.
Takahashi, M.
Yamanishi, K.
Cis and trans elements regulating expression of the varicella-zoster virus gI gene	57	(14)
He, H.
Boucaud, D.
Hay, J.
Ruyechan, W. T.
Interactions among structural proteins of varicella-zoster virus	71	(10)
Spengler, M.
Niesen, N.
Grose, C.
Ruyechan, W. T.
Hay, J.
The role of varicella-zoster virus immediate-early proteins in latency and their potential use as components of vaccines	81	(10)
Sadzot-Delvaux, C.
Rentier, B.
Mutagenesis of the varicella-zoster virus genome: lessons learned	91	(8)
Cohen, J. I.
Immune evasion mechanisms of varicella-zoster virus	99	(10)
Abendroth, A.
Arvin, A.
Pathway of viral spread in herpes zoster: detection of the protein encoded by open reading frame 63 of varicella-zoster virus in biopsy specimens	109	(12)
Iwasaki, T.
Muraki, R.
Kasahara, T.
Sato, Y.
Sata, T.
Kurata, T.
Vaccination against cytomegalovirus	121	(14)
Plotkin, S. A.
Varicella-zoster virus in human and rat tissue specimens	135	(8)
Annuziatio, P. W.
Lungu, O.
Panagiotidis, C.
In vitro measurement of human T cell responses to varicella zoster virus antigen	143	(8)
Hayward, A. R.
Use of varicella vaccines to prevent herpes zoster in older individuals	151	(10)
Levin, M. J.
Immunization of the elderly to boost immunity against varicella-zoster virus (VZV) as assessed by VZV skin test reaction	161	(12)
Takahashi, M.
Kamiya, H.
Asano, Y.
Shiraki, K.
Baba, K.
Otsuka, T.
Hirota, T.
Yamanishi, K.
Varicella-zoster virus immunity and prevention: a conference perspective	173
Straus, S. E.